Rhythm Pharmaceuticals Inc logo

Rhythm Pharmaceuticals Inc

RYTM
Healthcare|Biotechnology|USA
$108.40
-7.08 (-6.13%)
Tangible Book
$1.72

Upcoming Data Readouts (15)

Jul 2026
Est. completion
Ventricular Tachycardia (VT)
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
NCT06745778n=50
Aug 2026
Est. completion
Bradycardia Sinus
The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG
NCT06910059n=40
Sep 2026
Est. completion
PFA Ablation and LAAC Procedures
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
NCT07041125n=120
Oct 2026
Est. completion
P2Prader-Willi Syndrome
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
NCT06772597n=18
Feb 2027
Est. completion
NAAverage Length of Stay
Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.
NCT07514286n=80
Feb 2027
Est. completion
P2Arrhythmogenic Cardiomyopathy
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
NCT06174220n=120
Mar 2027
Est. completion
P3Hypothalamic Obesity
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
NCT06760546n=39
Oct 2027
Est. completion
NAReduction in the Initial Length of Stay
An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care.
NCT07552805n=490
Nov 2027
Est. completion
P1P2Hypothalamic Obesity
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
NCT06239116n=150
Dec 2027
Est. completion
Atrial Fibrillation
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
NCT06056271n=400
Aug 2028
Est. completion
NAHeart Failure With Preserved Ejection Fraction (HFpEF)
ELEVATE-HFpEF Clinical Study
NCT06678841n=700
Dec 2028
Est. completion
Paroxysmal Atrial Fibrillation
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071n=20,000
Dec 2030
Est. completion
P4Bardet Biedl Syndrome (BBS)
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
NCT07674290n=200
May 2031
Est. completion
NASpinal Deformity
The Ailliance Post-Market Clinical Study
NCT05856370n=1,000
Aug 2032
Est. completion
Intracranial Aneurysm
Neurovascular Product Surveillance Registry
NCT02988128n=4,000

Awaiting Results (9)

Trials past primary completion date but still active — data readout may be imminent.

Apr 2026
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
NCT06354777
Apr 2026
Destination Therapy Post Approval Study
NCT03681210
Mar 2026
Early Genetic Identification of Obesity
NCT06239064
Dec 2025
P3
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
NCT05093634
Dec 2025
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
NCT07092774
Oct 2025
Cardiac Implantable Electronic Device (CIED) Research Study
NCT05061862
Mar 2025
P3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
NCT05774756
Dec 2023
Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study)
NCT06606288
Jun 2013
NA
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NCT01321073

Recent Press Releases